Assessing ciliary function in polycystic kidney disease: beyond the kidney

Area of Science:

• Nephrology
• Pulmonology

Background:

• Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder.
• Mucociliary clearance is a crucial defense mechanism in the airways.

Purpose of the Study:

• To investigate the impact of ADPKD and tolvaptan on nasal mucociliary clearance.
• To assess if tolvaptan improves hydration status in ADPKD patients.

Main Methods:

• Cross-sectional study comparing 30 ADPKD patients on tolvaptan, 30 ADPKD patients not on tolvaptan, and 30 healthy controls.
• Nasal mucociliary clearance time measured using the saccharin transit time test.
• Urine specific gravity compared between tolvaptan and non-tolvaptan groups.

Main Results:

• Average mucociliary clearance time was 9 for ADPKD patients and 11 for controls.
• No significant difference in mucociliary clearance time between ADPKD patients on tolvaptan (9) and those not on tolvaptan (9).
• Tolvaptan significantly reduced urine specific gravity (1004 vs. 1011), indicating improved hydration.

Conclusions:

• Tolvaptan improves hydration in ADPKD patients but does not significantly enhance nasal mucociliary clearance.
• Mucociliary clearance in ADPKD patients is comparable to that observed in chronic kidney disease cohorts.